StockCIK 1725160
Zentalis Pharmaceuticals, Inc. (ZNTL): Insider Trades and Fund Holdings
In the past 12 months, Zentalis Pharmaceuticals, Inc. insiders reported 1 open-market purchase worth $15.2M and 0 sales worth $0.
1Insider buys, 12 months
$15.2MBought by insiders, 12 months
$0Sold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 19, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 19 | Walters Group10% owner | ▲ BUY | $15.2M |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Walters Group | 10% owner | 1 | $15.2M | 0 | $0 |
Tracked funds that report ZNTL
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 1,609,078 | $7.80M | ▼ −17.0% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →